Lawyers for the Lifecycle of Foods, Dietary Supplements,
Cosmetics, Drugs & Medical Devices
Amin Talati Adds Medical Device Patent Practice With Addition of Partner in Chicago
Leading regulatory and intellectual property law firm Amin Talati Wasserman LLP today announced that prominent medical technology patent attorney Peter Paredes has joined the firm as a partner in Chicago. CHICAGO (PRWEB) JANUARY 21, 2021 Peter MORE >
see all news >Food & Beverage
We support clients throughout the entire lifecycle of products aimed at improving the population's health and wellness: food and beverages, nutritional supplements, and cosmetics.
MOREIntellectual Property
Drawing heavily on our IP, patent and trademark expertise, we provide our clients with business advice and strategies that enhance product value and head off future litigation.
MORELitigation
We are deeply experienced in FDA and FTC disputes, patent and trademark infringement cases, class actions, breach of contract and unfair competition claims. We are renowned in the area of Paragraph IV litigation, where companies challenge brand name patents so that medications can be marketed in generic forms.
MOREDrugs & Devices
We provide strategic advice to clients from the inception of their drug and device products with a focus on enhancing product value, gaining regulatory approvals, and ensuring compliance.
MORE-
news
NutraStrong Podcast: Dietary Supplement Claims, Lawsuits and Class Actions – It’s Not Like You See on TV! With Ivan Wasserman
NutraStrong Podcast Mar 26, 2021 So you’ve seen a couple episodes of law and order and you think you understand the legal world.. not so fast! In this NutraStrong episode with none other than Ivan Wasserman, he takes us behind the scenes of the legal world- in relation to dietary supplements. You’ll get a good […]
-
news
FDA immediately exempts 7 medical devices from the 510(k) requirement and proposes to exempt an additional 83 more.
The COVID-19 public health emergency brought about a sudden and unexpected need for personal protective equipment and other medical devices. In response, the Food and Drug Administration (FDA) issued a number of guidance documents that, among other things, waived the premarket notification (510(k)) requirement for the lawful distribution of these devices during the public health […]
-
news
Evan Phelps To Present Webinar On Breakthrough Medical Devices
Monday, Nov. 16, 2020 • 1:30 p.m. – 3:00 p.m. EST In the past, it’s been difficult to get marketing authorization from the FDA for novel medical device technologies — and even if those authorizations were made, it could take years for a Centers for Medicare and Medicaid Services (CMS) coverage decision. Not anymore. With […]
